Related Experiment Video
Updated: Oct 9, 2026

Modulation of Tau Subcellular Localization as a Tool to Investigate the Expression of Disease-related Genes
Published on: December 20, 2019
Three different human tau isoforms and rat neurofilament light, middle and heavy chain proteins are cellular
A J Grierson1, G V Johnson, C C Miller
1Department of Neuroscience, The Institute of Psychiatry, De Crespigny Park, Denmark Hill, SE5 8AF, London, UK.
Abstract:
Abnormal aggregates of tau and neurofilaments are pathologies of Alzheimer's disease. Some of these aggregates are insoluble in chaotropic salts and ionic detergents but the mechanisms that lead to this are not clear. One suggestion is that it is due to crosslinking by tissue transglutaminase. Both tau and neurofilaments can be crosslinked by transglutaminase in vitro and one isoform of tau is now known to be a cellular transglutaminase substrate. However there is no evidence to demonstrate that neurofilaments are cellular substrates for transglutaminase and it is not clear whether other isoforms of tau are equally susceptible to transglutaminase crosslinking. Here, we demonstrate that three different tau isoforms and neurofilament light, middle and heavy chain proteins are all cellular substrates for transglutaminase.
More Related Videos
07:24A Split-Luciferase Complementation Assay for Temporally Resolved Measurement of Tau Clearance in Microglia
Published on: July 24, 2026
07:54Purification of Tubulin with Controlled Posttranslational Modifications and Isotypes from Limited Sources by Polymerization-Depolymerization Cycles
Published on: November 5, 2020
Related Concept Videos
Types of Intermediate Filaments
Enzyme-linked Receptors
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...